{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:47:35Z","timestamp":1781308055032,"version":"3.54.1"},"reference-count":37,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1004,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/ane.12028","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T02:49:02Z","timestamp":1356144542000},"page":"63-69","source":"Crossref","is-referenced-by-count":17,"special_numbering":"supplement s195","title":["Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore"],"prefix":"10.1155","volume":"126","author":[{"given":"T.","family":"Holm\u00f8y","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8.","family":"Torkildsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-M.","family":"Myhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. I.","family":"L\u00f8ken-Amsrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"10.1111\/ane.12028-BIB0001|ane12028-cit-0001","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1177\/1352458511425366","article-title":"Prevention and treatment of MS: studying the effects of vitamin D","volume":"17","author":"Munger","year":"2011","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12028-BIB0002|ane12028-cit-0002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.22043","article-title":"Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis","volume":"68","author":"Simpson","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12028-BIB0003|ane12028-cit-0003","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00415-011-6226-3","article-title":"Patterns of dietary and herbal supplement use by multiple sclerosis patients","volume":"259","author":"O'connor","year":"2012","journal-title":"J Neurol"},{"key":"10.1111\/ane.12028-BIB0004|ane12028-cit-0004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.0b013e31825fdf01","article-title":"Vitamin D and disease activity in multiple sclerosis before and during interferon beta treatment","volume":"79","author":"L\u00f8ken Amsrud","year":"2012","journal-title":"Neurology"},{"key":"10.1111\/ane.12028-BIB0005|ane12028-cit-0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000339360","article-title":"Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian multiple sclerosis patients","volume":"39","author":"\u0160altyte Benth","year":"2012","journal-title":"J Neuroepidemiol"},{"key":"10.1111\/ane.12028-BIB0006|ane12028-cit-0006","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/ane.12028-BIB0007|ane12028-cit-0007","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1352458508094399","article-title":"Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis","volume":"14","author":"Smolders","year":"2008","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12028-BIB0008|ane12028-cit-0008","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.21972","article-title":"Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis","volume":"67","author":"Mowry","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12028-BIB0009|ane12028-cit-0009","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archneurol.2012.283","article-title":"Omega-3 fatty acid treatment in multiple sclerosis (OFAMS study): a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Torkildsen","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12028-BIB0010|ane12028-cit-0010","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1073\/pnas.1001119107","article-title":"UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production","volume":"107","author":"Becklund","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ane.12028-BIB0011|ane12028-cit-0011","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e31820af93d","article-title":"Sun exposure and vitamin D are independent risk factors for CNS demyelination","volume":"76","author":"Lucas","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12028-BIB0012|ane12028-cit-0012","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archneur.65.6.809","article-title":"Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis","volume":"65","author":"Torkildsen","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12028-BIB0013|ane12028-cit-0013","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ana.22678","article-title":"Rare variants in the CYP27B1 gene are associated with multiple sclerosis","volume":"70","author":"Ramagopalan","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12028-BIB0014|ane12028-cit-0014","doi-asserted-by":"crossref","first-page":"e26262","DOI":"10.1371\/journal.pone.0026262","article-title":"Dietary vitamin D3 supplements reduce demyelination in the cuprizone model","volume":"6","author":"Wergeland","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1111\/ane.12028-BIB0015|ane12028-cit-0015","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/j.1600-0404.2011.01577.x","article-title":"Intrathecal levels of vitamin D and IgG in multiple sclerosis","volume":"125","author":"Holmoy","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12028-BIB0016|ane12028-cit-0016","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182343274","article-title":"A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis","volume":"77","author":"Stein","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12028-BIB0017|ane12028-cit-0017","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1352458511434607","article-title":"Effect of vitamin D3 supplementation on relapses, disease progression and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial","volume":"18","author":"Kampman","year":"2012","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12028-BIB0018|ane12028-cit-0018","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00415-011-5980-6","article-title":"Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial","volume":"258","author":"Steffensen","year":"2011","journal-title":"J Neurol"},{"key":"10.1111\/ane.12028-BIB0019|ane12028-cit-0019","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-9877(86)90010-1","article-title":"Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D","volume":"21","author":"Goldberg","year":"1986","journal-title":"Med Hypotheses"},{"key":"10.1111\/ane.12028-BIB0020|ane12028-cit-0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002826-200303000-00001","article-title":"Alfacalcidol treatment in multiple sclerosis","volume":"26","author":"Achiron","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/ane.12028-BIB0021|ane12028-cit-0021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-5728(02)00396-X","article-title":"Cytokine profile in patients with multiple sclerosis following vitamin D supplementation","volume":"134","author":"Mahon","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1111\/ane.12028-BIB0022|ane12028-cit-0022","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","article-title":"A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis","volume":"76","author":"Wingerchuk","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12028-BIB0023|ane12028-cit-0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcn\/86.3.645","article-title":"Safety of vitamin D3 in adults with multiple sclerosis","volume":"86","author":"Kimball","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/ane.12028-BIB0024|ane12028-cit-0024","doi-asserted-by":"crossref","first-page":"e15235","DOI":"10.1371\/journal.pone.0015235","article-title":"Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis","volume":"5","author":"Smolders","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/ane.12028-BIB0025|ane12028-cit-0025","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","article-title":"A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis","volume":"74","author":"Burton","year":"2010","journal-title":"Neurology"},{"key":"10.1111\/ane.12028-BIB0026|ane12028-cit-0026","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2011-0325","article-title":"Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis","volume":"96","author":"Kimball","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/ane.12028-BIB0027|ane12028-cit-0027","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1177\/1352458511412655","article-title":"Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis","volume":"17","author":"Knippenberg","year":"2011","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12028-BIB0028|ane12028-cit-0028","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/08820139.2011.573041","article-title":"Therapeutic effect of vitamin D3 in multiple sclerosis patients","volume":"40","author":"Mosayebi","year":"2011","journal-title":"Immunol Invest"},{"key":"10.1111\/ane.12028-BIB0029|ane12028-cit-0029","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","article-title":"A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis","volume":"83","author":"Soilu-Hanninen","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12028-BIB0030|ane12028-cit-0030","first-page":"195","article-title":"A comparative study of 25 (OH) vitamin D serum levels in patients with multiple sclerosis and control group in Isfahan, Iran","volume":"1","author":"Shaygannejad","year":"2010","journal-title":"Int J Prev Med"},{"key":"10.1111\/ane.12028-BIB0031|ane12028-cit-0031","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/1352458511426739","article-title":"Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers","volume":"18","author":"Bazelier","year":"2012","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12028-BIB0032|ane12028-cit-0032","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1212\/WNL.0b013e3182242d34","article-title":"Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome","volume":"77","author":"Moen","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12028-BIB0033|ane12028-cit-0033","volume-title":"Daily reference values for calcium and vitamin D","author":"Institute of Medicine","year":"2011"},{"key":"10.1111\/ane.12028-BIB0034|ane12028-cit-0034","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.beem.2011.06.009","article-title":"Why the minimum desirable serum 25-hydroxyvitamin D level should be 75\u00a0nmol\/L (30\u00a0ng\/ml)","volume":"25","author":"Vieth","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1111\/ane.12028-BIB0035|ane12028-cit-0035","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1562\/2004-11-19-RN-375","article-title":"Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness","volume":"81","author":"Engelsen","year":"2005","journal-title":"Photochem Photobiol"},{"key":"10.1111\/ane.12028-BIB0036|ane12028-cit-0036","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/77.1.204","article-title":"Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol","volume":"77","author":"Heaney","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/ane.12028-BIB0037|ane12028-cit-0037","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-5448.2010.00672.x","article-title":"Vitamin D status in Norwegian children and adolescents with excess body weight","volume":"12","author":"Lagunova","year":"2011","journal-title":"Pediatr Diabetes"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12028","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12028\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T23:14:59Z","timestamp":1714778099000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1111\/ane.12028","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}